Patents by Inventor Eli Chaim LEWIS

Eli Chaim LEWIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALPHA-1-ANTITRYPSIN MUTANTS, COMPOSITIONS COMPRISING SAME, AND USE THEREOF
    Publication number: 20230068487
    Abstract: The present invention includes mutants of human alpha-1-antitrypsin (mhAAT). Further provided are compositions including the mhAAT and use of same, such as for modulating an immune cell, and treating a condition, such as inflammation.
    Type: Application
    Filed: January 28, 2021
    Publication date: March 2, 2023
    Inventors: Yotam LIOR, Eli Chaim LEWIS
  • Mutant alpha-1-antitrypsin compositions and use thereof
    Patent number: 11492390
    Abstract: The present invention provides mutant alpha 1-antitrypsin proteins, pharmaceutical compositions comprising the same, and methods of use thereof in treatment of subjects with an inflammatory disease or disorder.
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: November 8, 2022
    Assignee: B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
    Inventors: Eli Chaim Lewis, Yotam Lior
  • METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING DIABETES
    Publication number: 20210052777
    Abstract: The present invention is directed to, inter alia, a scaffold-cell construct including a biocompatible polymer (e.g., poly-l-lactic acid (PLLA) and polylactic glycolic acid (PLGA)) and recombinant cells having increased GLUT4 levels and/or activity. The invention is further directed to methods for reducing glucose levels in a subject in need thereof. Also provided are methods of producing the scaffold-cell construct of the invention.
    Type: Application
    Filed: February 4, 2019
    Publication date: February 25, 2021
    Inventors: Shulamit LEVENBERG, Eddy KARNIELI, Eli Chaim LEWIS, Margarita BECKERMAN, Chava HAREL
  • MUTANT ALPHA-1-ANTITRYPSIN COMPOSITIONS AND USE THEREOF
    Publication number: 20200140524
    Abstract: The present invention provides mutant alpha 1-antitrypsin proteins, pharmaceutical compositions comprising the same, and methods of use thereof in treatment of subjects with an inflammatory disease or disorder.
    Type: Application
    Filed: April 2, 2018
    Publication date: May 7, 2020
    Inventors: Eli Chaim LEWIS, Yotam LIOR